Key result
Smartwatch blood pressure monitors fall short of recommendations for primary clinical use.
Why the study?
The clinical reliability of blood pressure measurements obtained using cuff-based and cuffless smartwatches required evaluation based on current evidence.
Are smartwatch-based blood pressure measurements clinically reliable compared to standard methods?
Are smartwatch-based blood pressure measurements clinically reliable compared to standard methods?
Answers are grounded in this paper and cite their sources.
While smartwatch-based blood pressure monitoring is promising, current technologies lack the consistent accuracy required to be recommended as a primary method of clinical assessment.
Aim: this narrative review evaluates the current evidence regarding the reliability of blood pressure measurements obtained using both cuff-based and cuffless smartwatches. Methods: narrative review included evidence from prospective cohort studies, observational studies, controlled trials, validation studies, narrative reviews, and randomized controlled trials, identified through searches of PubMed/MEDLINE, Embase, Web of Science, and Google Scholar. Results: available studies suggests a relative advantage of cuff-based smartwatches over cuffless devices in terms of measurement accuracy. However, the findings remain inconsistent, with studies providing conflicting results for both technologies, highlighting the need for further high-quality validation. Conclusion: both cuff-based and cuffless smartwatches are promising tools for continuous blood pressure monitoring, but they are still not recommended as a primary method of blood pressure assessment. Their clinical use requires further standardization, validation, and confirmation of real diagnostic value.
No takes yet. Share an insight, caveat, or question.
Fimiarz et al. (2026) conducted a review in Hypertension. Smartwatch-based blood pressure measurements (cuff-based and cuffless) vs. Traditional clinical blood pressure measurement methods was evaluated on Measurement accuracy and reliability. While cuff-based smartwatches show a relative advantage in accuracy over cuffless devices, neither technology is currently recommended as a primary method for clinical blood pressure assessment.
Synapse has enriched 10 related papers. Consider them for comparative context: